Abstract
Objective: To compare test acceptability and compliance of two surveillance strategies in a high-risk group of women who were all BRCA mutation carriers over a 23-month follow-up period, (1) a new surveillance strategy based on assessment of serum CA-125 and HE4 every 4 months using a Risk of Ovarian Cancer Algorithm (ROCA) and (2) standard of care (SOC) surveillance with a CA-125 blood test and a pelvic ultrasound examination every 6 months were conducted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
